PROGRAMME - DAY 1: Thursday, May 27

 
ROZA IRYS
08:00-09:00 Registration
09:00-10:00 ESMI Plenary Lecture 1
Roza & Irys
Transcription factors dynamics: from discrete pulses to oscillatory pattern to control gene expression
Violaine See (Liverpool, UK)
Co-Chairs: Clemens Lowik (Leiden, The Netherlands), Leszek Krolicki (Warsaw, Poland)
10:00-10:30 Coffee break & Exhibition
10:30-12:00 Parallel Session 1: Cancer I (together with ESR)
Co-Chairs: Markus Schwaiger (Munich, Germany), Peter Brader (Vienna, Austria)
Parallel Session 2: Neuroscience I
Co-Chairs: Annemie van der Linden (Antwerp, Belgium), David Wyper (Glasgow, UK), Hervé Boutin (Manchester, UK)
10:30-10:45 Multimodal imaging approaches for cell-cell interaction, Stephan Maßberg (Munich, Germany) [11C](R)-PK11195- a tricky tracer. Do we really need it to image microglial activation?
Alex Gerhard (Manchester, UK)
10:45-11:00 Molecular imaging for monitoring treatment with protein kinase inhibitors, Wolfgang Weber (Freiburg, Germany) YIA Applicant's Presentation: Preclinical imaging of the type 1 cannabinoid receptor in neurodegenerative diseases, Cindy Casteels (Leuven, Belgium)
11:00-11:15 Potentials of imaging biomarkers inpatients
Bernard Van Beers (Paris, France)
YIA Applicant's Presentation: Longitudinal non-invasive detection of amyloid plaques by combined molecular, functional and morphological imaging in transgenic mouse models of alzheimers disease, Florian C. Maier (Tübingen, Germany)
11:15-11:30 YIA Applicant's Presentation: Pre-clinical screening of anti - her2 nanobodies for molecular imaging of breast cancer, Ilse Vaneycken (Brussels, Belgium) Serotonergic neurotransmission in early alzheimer’s disease, Steen G. Hasselbalch (Copenhague, Denmark)
11:30-11:45 YIA Applicant's Presentation: [18f]-fdg/[18f]-flt-pet and bioluminescence imaging of therapy response in b-cell lymphoma mice treated with cytotoxic and antiproliferative agents, Marijke De Saint-Hubert (Leuven, Belgium) Qualitative and quantitative assessment of florbetapir f-18 pet (18f-av45) amyloid deposition pet imaging - validation by pathology. preliminary report, Grzegorz Romanowicz (Gdańsk, Poland)
11:45-12:00 tf-pimonidazole: an hypoxia marker suitable for in vivo 19f mrs imaging, Arend Heerschap (Nijmegen, The Netherlands) YIA Applicant's Presentation: In-vivo imaging of a mouse traumatic brain injury model using dual-isotope quantitative spect/ct, Domokos Máthé (Budapest, Hungary)
12:00-13:00 Lunch Break
13:00-14:30 Parallel Session 3: Technology

Co-Chairs: Jorge Ripoll (Heraklion, Greece), Markus Rudin (Zürich, Switzerland)
Parallel Session 4: Probes I (together with COST action D38)
Co-Chairs: Eva Jakab-Tóth (Orléans, France), Silvio Aime (Torino, Italy)
13:00-13:15 Molecular analysis of adaptive immune function through microscopic and mesoscopic imaging
Jens Stein (Bern, Switzerland)
The alignment of target-specific lipoCEST MRI contrast agents
Sander Langereis (Eindhoven, The Netherlands)
13:15-13:30 Magnetic resonance imaging: from structure to molecular interactions
Markus Rudin (Zürich, Switzerland)
Lanthanide-based in vivo luminescence imaging
Stephane Petoud (Orléans, France and Pittsburgh, US)
13:30-13:45 Imaging Modalities: PET and SPECT
Sibylle Ziegler (Munich, Germany)
New perspectives for imaging molecules and metabolism in vivo
Rolf Gruetter (Lausanne, Switzerland)
13:45-14:00 In vivo fluorescence kinetic imaging for improved contrast and studies of temporal and quantitative biodistribution, James Mansfield (Cambridge, UK) YIA Applicant's Presentation: In vivo biodistribution of radiolabeled matrix metalloproteinase-2 activatable cell penetrating peptides, Sander Van Duijnhoven (Eindhoven, The Netherlands)
14:00-14:15 Cerenkov radiation imaging of a xenograft murine model of mammary carcinoma, Federico Boschi (Verona, Italy) YIA Applicant's Presentation: Bioresponsive mri contrast agents based on self-assembling beta-cyclodextrin nanocapsules, Jonathan Martinelli (Alessandria, Italy)
14:15-14:30 4d (3d+kinetics) molecular imaging in bioluminescence and fluorescence, Serge Maitrejean (Paris, France) Photochemical activation of endosomal escape of mri-gd-agents in tumor cells, Eliana Gianolio (Torino, Italy)
14:30-16:00 Guided Poster Session1 with Coffee break
14:30-16:00 Poster Walk 1: Imaging Cancer Biology
(P001-P012) & (P105-P106)
Co-Chairs:
Fabian Kiessling (Aachen, Germany)
Markus Rudin (Zürich, Switzerland)
Poster Walk 2: Technology & Data Analysis Methods
P070-P078) & (P097-P104)
Co-Chairs:
Serge Maitrejean (Paris, France)
Adriaan Lammertsma (Amsterdam, The Netherlands)
Poster Walk 3: Molecular Neuroimaging
(P034-P047) & (P107)
Co-Chairs:
Sabina Pappata (Naples, Italy)
Andreas Jacobs (Muenster, Germany)
Poster Walk 4: Probe Design
(P058-P069)
Co-Chairs:
Frédéric Dollé (Orsay, France)
Helmut Maecke (Freiburg, Germany)
16:00-17:00 ESMI Plenary Lecture 2
Roza & Irys
Immune surveillance and autoimmunity: how encephalitogenic T cells enter their target organ
Francesca Odoardi (Göttingen, Germany)
Co-Chairs: Renata Mikolajczak (Warsaw, Poland), Chrit Moonen (Bordeaux, France)
17:00-18:00 Plenary Session on Excellent, Late Breaking, and YIA Abstracts
Roza & Irys
Co-Chairs: Renata Mikolajczak (Warsaw, Poland), Chrit Moonen (Bordeaux, France)
17:00-17:10 Exendin-4 derivatives labeled with radiometals for the detection of insulinoma: a “from bench to bed approach", Damian Wild (Freiburg, Germany)
17:10-17:20 YIA Applicant's Presentation: Assessment of hif transcriptional activity in a mouse tumor model using gpi anchored avidin- a novel protein reporter for in vivo imaging, Steffi Lehmann (Zürich, Switzerland)
17:20-17:30 YIA Applicant's Presentation: A leukocyte ligand of vascular adhesion protein-1 as an imaging tool in pet, Anu Autio (Turku, Finland)
17:30-17:40 YIA Applicant's Presentation: Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light, Merlijn Huttemann (Leiden, The Netherlands)
17:40-17:50 YIA Applicant's Presentation: Development of strategies for in vivo mri and optical imaging of neural stem cells distribution for the treatment of traumatic spinal cord injury, Ramona Lui (Milano, Italy)
17:50-18:00 Validation of bone marrow-derived stromal cell graft position by colocalisation of histology, bioluminescence and magnetic resonance imaging, Nathalie de Vocht (Antwerp, Belgium)